Results 141 to 150 of about 96,147 (311)
Statin therapy in cirrhosis may confer a survival benefit while reducing the risk of hepatic decompensation and hepatocellular carcinoma. ABSTRACT Background The role of statins in cirrhosis remains controversial. Historically restricted due to safety concerns, emerging evidence highlights potential pleiotropic benefits, though effects on mortality and
Bernardo de Faria Moraes +8 more
wiley +1 more source
Spontaneous Bacterial Peritonitis in Prehepatic Portal Hypertension: A Rare Complication. [PDF]
Mendoza-Rodríguez R +4 more
europepmc +1 more source
The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy [PDF]
Birgit A. P. M. Vogels +4 more
openalex +1 more source
Complications of endoscopic ligation of varicose veins in patients with portal hypertension
Bahadyr Bebezov, Talgat Abdykadyrov
openalex +2 more sources
Alpha‐1 antitrypsin deficiency is a genetic disease that affects the lungs and the liver. The role of the heterozygous genetic defect in the development of liver cancer in patients with cirrhosis is unclear. Our study found that carrying the Pi*MZ genotype increases the risk of developing liver cancer.
Lorenz Balcar +18 more
wiley +1 more source
Sustainability in Healthcare: The Role of Digital Technologies for Improving Patient Engagement
ABSTRACT Sustainability in healthcare is getting considerable research attention as systems worldwide tend to balance environmental, social, and economic factors. In this context, digital technologies have demonstrated significant potential to enhance engagement among different consumer groups across various industries.
Francesco Schiavone +4 more
wiley +1 more source
Textbook outcomes after splenectomy in patients with portal hypertension. [PDF]
Chen L +7 more
europepmc +1 more source
Moderate overexpression of wild‐type Met in hepatocytes (Alb‐R26Met mouse model) boosts a strong antioxidant response dependent on the glutathione system while impairing TGF‐β signaling in the liver. This leads to improved liver regeneration and protects against DDC‐induced injury, a model for cholestatic disease sharing features with primary ...
Carlos González‐Corralejo +16 more
wiley +1 more source
Portal hypertension caused by essential thrombocythemia: A case report. [PDF]
Fang Y +5 more
europepmc +1 more source

